ID   M91-054
AC   CVCL_1G26
SY   M91 054
DR   Cosmic; 1211154
DR   Wikidata; Q54903652
RX   PubMed=10952317;
RX   PubMed=23039341;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
RX   PubMed=10952317; DOI=10.1038/35020115;
RA   Bittner M., Meltzer P.S., Chen Y.-D., Jiang Y., Seftor E.A.,
RA   Hendrix M.J.C., Radmacher M.D., Simon R.M., Yakhini Z., Ben-Dor A.,
RA   Sampas N., Dougherty E., Wang E., Marincola F.M., Gooden G.C., Lueders J.,
RA   Glatfelter A., Pollock P.M., Carpten J.D., Gillanders E.M., Leja D.,
RA   Dietrich K., Beaudry C., Berens M.E., Alberts D.S., Sondak V.K.,
RA   Hayward N.K., Trent J.M.;
RT   "Molecular classification of cutaneous malignant melanoma by gene
RT   expression profiling.";
RL   Nature 406:536-540(2000).
//
RX   PubMed=23039341; DOI=10.1186/1476-4598-11-75; PMCID=PMC3554420;
RA   Byron S.A., Loch D.C., Wellens C.L., Wortmann A., Wu J.-Y., Wang J.,
RA   Nomoto K., Pollock P.M.;
RT   "Sensitivity to the MEK inhibitor E6201 in melanoma cells is
RT   associated with mutant BRAF and wildtype PTEN status.";
RL   Mol. Cancer 11:75.1-75.15(2012).
//